Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Assets (2017 - 2021)

Historic Assets for Cogent Biosciences (COGT) over the last 5 years, with Q3 2021 value amounting to $215.4 million.

  • Cogent Biosciences' Assets rose 5398.94% to $215.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $215.4 million, marking a year-over-year increase of 5398.94%. This contributed to the annual value of $250.9 million for FY2020, which is 40769.08% up from last year.
  • Latest data reveals that Cogent Biosciences reported Assets of $215.4 million as of Q3 2021, which was up 5398.94% from $228.5 million recorded in Q2 2021.
  • In the past 5 years, Cogent Biosciences' Assets ranged from a high of $250.9 million in Q4 2020 and a low of $31.1 million during Q2 2020
  • Moreover, its 5-year median value for Assets was $83.6 million (2018), whereas its average is $111.0 million.
  • Its Assets has fluctuated over the past 5 years, first tumbled by 5519.28% in 2020, then surged by 63584.29% in 2021.
  • Quarter analysis of 5 years shows Cogent Biosciences' Assets stood at $49.1 million in 2017, then surged by 74.95% to $85.9 million in 2018, then crashed by 42.48% to $49.4 million in 2019, then surged by 407.69% to $250.9 million in 2020, then fell by 14.16% to $215.4 million in 2021.
  • Its Assets stands at $215.4 million for Q3 2021, versus $228.5 million for Q2 2021 and $237.6 million for Q1 2021.